North American Prodromal Synucleinopathy Consortium

Recruiting

Trial ID: NCT03623672

Age - 18 Years-N/A Gender - All Accepting Healthy Volunteers - No

Purpose

This study will enroll participants with idiopathic rapid eye movement (REM) sleep behavior disorder (RBD), for the purpose of preparing for a clinical trial of neuroprotective treatments against synucleinopathies.

Official Title

North American Prodromal Synucleinopathy Consortium

Stanford Investigator(s)

Emmanuel During, MD

Eligibility


Inclusion Criteria:

   - Idiopathic REM sleep behavior disorder

Exclusion Criteria:

   - REM sleep behavior disorder secondary to another cause (ex: narcolepsy, dementia,
   Parkinson's Disease, etc)

   - Other neurological disorder

View More
View Less

Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305

©2024 Stanford Medicine